University of California (Irvine) Gynecologic Oncology

Topics

• Ovarian cancer diagnosis and treatment 496
• Endometrial and Cervical Cancer Treatments 446
• Cervical Cancer and HPV Research 165
• HER2/EGFR in Cancer Research 84
• Lymphoma Diagnosis and Treatment 75
• Uterine Myomas and Treatments 68
• PARP inhibition in cancer therapy 57
• Intraperitoneal and Appendiceal Malignancies 50
• Immunotherapy and Immune Responses 45
• Viral-associated cancers and disorders 26
• Cancer Immunotherapy and Biomarkers 23
• Cancer Risks and Factors 20

Most cited

1. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms.

   Leukemia · 2022 · 3,530 citations · John Chan

2. Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer.

   The New England journal of medicine · 2023 · 703 citations · Dana Chase

3. Uterine Neoplasms, Version 1.2023, NCCN Clinical Practice Guidelines in Oncology.

   Journal of the National Comprehensive Cancer Network : JNCCN · 2023 · 486 citations · Ernest Han

4. Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer.

   The New England journal of medicine · 2023 · 633 citations · Robert Mannel

5. Lenvatinib plus Pembrolizumab for Advanced Endometrial Cancer.

   The New England journal of medicine · 2022 · 797 citations · Alessandro Santin

6. Recent advances and clinical applications of deep learning in medical image analysis.

   Medical image analysis · 2022 · 535 citations · Robert Mannel

7. Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer.